76308-27-5 Suppliers

Recommended suppliersmore

76308-27-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 76308-27-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,3,0 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 76308-27:
(7*7)+(6*6)+(5*3)+(4*0)+(3*8)+(2*2)+(1*7)=135
135 % 10 = 5
So 76308-27-5 is a valid CAS Registry Number.

76308-27-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name	methyl 2-((1r,4r)-4-aminocyclohexyl)acetate

1.2 Other means of identification

Product number	-
Other names	-

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:76308-27-5 SDS

76308-27-5Upstream product

76308-27-5Downstream Products

76308-27-5Relevant articles and documents

Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4- tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB- 277011): A potent and selective dopamine D3 receptor antagonist with high oral bioavailability and CNS penetration

Stemp, Geoffrey,Ashmeade, Tracey,Branch, Clive L.,Hadley, Michael S.,Hunter, A. Jacqueline,Johnson, Christopher N.,Nash, David J.,Thewlis, Kevin M.,Vong, Antonio K. K.,Austin, Nigel E.,Jeffrey, Phillip,Avenell, Kim Y.,Boyfield, Izzy,Hagan, Jim J.,Middlemiss, Derek N.,Reavill, Charlie,Riley, Graham J.,Routledge, Carole,Wood, Martyn

, p. 1878 - 1885 (2000)

A selective dopamine D3 receptor antagonist offers the potential for an effective antipsychotic therapy, free of the serious side effects of currently available drugs. Using clearance and brain penetration studies as a screen, a series of 1,2,3

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 76308-27-5

CAS

76308-27-5